Table 2 Antifungal susceptibility testing of T. mycotoxinivorans isolated in 2012 (Morphotype 1 and Morphotype 2) and 2013
s503348/2012 | s503348/2012 | s503026/2013 | |
|---|---|---|---|
Morphotype 1 | Morphotype 2 | ||
Antifungal agent | MICa | MICa | MICa |
Amphotericin B | 0.5 | 2.0 | 0.25 |
Anidulafungin | >8.0 | >8.0 | >8.0 |
Micafungin | >8.0 | >8.0 | >8.0 |
Caspofungin | >8.0 | >8.0 | >8.0 |
Flucytosine | 16 | 32.0 | 64 |
Posaconazole | 0.06 | 0.25 | 0.12 |
Voriconazole | 0.03 | 0.12 | 0.03 |
Itraconazole | 0.015 | 0.25 | 0.03 |
Fluconazole | 2.0 | 8.0 | 4.0 |